Remove 2010 Remove Adverse Reactions Remove Pharmaceutical Companies
article thumbnail

Innovation in immuno-oncology: Leading companies in oncolytic viral proteins

Pharmaceutical Technology

A major strategy for OV development is genetic manipulation to weaken virus pathogenicity, enhance target selectivity, reduce adverse reactions, and/or insert exogenous therapeutic genes into the virus genome. OVs can be attenuated natural viruses or recombinant viruses.

article thumbnail

What to Keep in Your Integrative Medicine Cabinet

The Thyroid Pharmacist

Discontinue use should adverse reactions occur. Discontinue use should adverse reactions occur. For this reason, most supplement companies do not take the extra steps to test their products to ensure safety and purity. Pharmaceuticals (Basel). Published 2010 Jan 19. 2010;3(1):188-224.